C. Bona
Management of anticoagulation in devices
Quiz Summary
0 of 5 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 5 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 5
1. Question
At the time of device surgery, continued VKA (warfarin) at a normal therapeutic target is __________ to bridging therapy.
CorrectIncorrect -
Question 2 of 5
2. Question
If you bridge a patient on heparin (instead of uninterrupted OACs), what happens to the risk of hematoma?
CorrectIncorrect -
Question 3 of 5
3. Question
Adding anti-platelets medications to NOACs in patients with stable coronary artery disease; after 1 year from last intervention…
CorrectIncorrect -
Question 4 of 5
4. Question
At the time of surgery of the CIED Implant, receiving anti-platelets in addition to VKA:
CorrectIncorrect -
Question 5 of 5
5. Question
Applying compression dressings after device implants was associated with which of the following:
CorrectIncorrect
